Cavalier Jason 4
4 · Lyra Therapeutics, Inc. · Filed Feb 1, 2024
Insider Transaction Report
Form 4
Cavalier Jason
Chief Financial Officer
Transactions
- Award
Stock Options
2024-01-30+200,000→ 200,000 totalExercise: $4.58Exp: 2034-01-29→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 30, 2024.